Decrease in lipoatrophy in a pilot study using a short-term treatment interruption strategy for 48 weeks in São Paulo, Brazil

AIDS Research and Human Retroviruses

Volumn 28, Issue 8, 2012, Pages 747-748

  Gosuen, Gisele Cristina ^a   Turcato, Gilberto ^a   Salomao, Reinaldo ^a   Lewi, David Salomao ^a   Diaz, Ricardo Sobhie ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; GLUCOSE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LIPID; STAVUDINE;

ADULT; ANTHROPOMETRY; BODY FAT; BONE DENSITY; BRAZIL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DRUG EXPOSURE; DRUG HALF LIFE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; LIPID BLOOD LEVEL; LIPOATROPHY; MALE; OUTPATIENT DEPARTMENT; PILOT STUDY; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT PLANNING; VIREMIA; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; BRAZIL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; PILOT PROJECTS; VIRAL LOAD;

EID: 84864204599     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0292     Document Type: Letter

References (6)

1. Lifson AR, Belloso WH, Davey RT, et al.: Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials 11:205-219.
2. Pirillo M, Palmisano L, Pellegrini M, et al.: Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: A substudy of the ISS-PART Trial. AIDS Res Hum Retroviruses 2010;26:541-545.
3. Durnin JV and Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
4. Ribaudo HJ, Haas DW, Tierney C, et al.: Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study. Clin Infect Dis 2006;42:401-407.
5. Cohen CJ, Colson AE, Sheble-Hall AG, McLaughlin KA, and Morse GD: Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the fivedays- on, two-days-off (FOTO) study. HIV Clin Trials 2007; 8:19-23.
6. Reynolds SJ, Kityo C, Hallahan CW, et al.: A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. PLoS One 2010;5:e10307.